A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naïve people with type 2 diabetes: A randomized, controlled trial

  1. Heise, T.
  2. Tack, C.J.
  3. Cuddihy, R.
  4. Davidson, J.
  5. Gouet, D.
  6. Liebl, A.
  7. Romero, E.
  8. Mersebach, H.
  9. Dykiel, P.
  10. Jorde, R.
Journal:
Diabetes Care

ISSN: 0149-5992 1935-5548

Year of publication: 2011

Volume: 34

Issue: 3

Pages: 669-674

Type: Article

DOI: 10.2337/DC10-1905 GOOGLE SCHOLAR lock_openOpen access editor